Regulatory & Legal

A coal company and a First Nation are building a workforce before a mine even exists. Is this a new blueprint for resource projects or a gamble on approval?

As storms intensify, a new threat emerges: sophisticated fraud networks. Discover the hidden systems fueling post-disaster scams and the digital dragnet fighting back.

With strong shareholder backing from its AGM, First Mining Gold is poised to advance its Canadian projects. A closer look reveals a nuanced investor picture.

A new Glencore-funded study finds residents' arsenic levels are normal, blaming diet, not the Horne Smelter. But it clashes with past public health warnings, leaving a community to weigh conflicting science.

The firm's addition of tax expert Ed Hannon isn't just a personnel move; it's a strategic play to dominate the booming Delaware Statutory Trust market.

A survey reveals 75% of lab researchers prioritize peptide quality over price, a clear signal against the backdrop of a scientific reproducibility crisis.

Mosaic Clinical Technologies launches an AI-native platform that assists radiologists in real time, aiming to boost capacity and fight burnout in a strained field.

A market poised for 31% annual growth signals a new era for Alcohol-associated Liver Disease. As pharma chases a cure, a new class of drugs emerges.

As AI costs soar and security risks mount, a new open-source microhypervisor aims to rebuild trust from the silicon up. Is this the architectural shift we need?

A $3M drone contract is just the beginning. A construction firm's pivot to AI warfare reveals a deeper story about software-defined battlefields.

As AI-powered scams and account takeovers surge, institutions are ditching old tools for unified platforms that turn operational data into a strategic weapon.

Phase 2a data shows a new drug not only stops bone-destroying cancer but heals the damage, with no adverse events. This is a strategic game-changer.

New data reveals a grim reality: Texas rural roads are nearly three times deadlier than city streets, exposing a deep infrastructure and safety crisis.

An Alpharetta firm's milestone isn't just about shingles; it's a strategic play challenging the costly replacement model with sustainable, life-extending tech.

ResVita Bio's new board member signals a major shift. We explore how visionary leadership and living medicine are converging to tackle long-neglected diseases.

Often ignored, printers and IoT devices are major security risks. A new operational model aims to finally solve the problem of who is responsible for their security.

Fresh Del Monte becomes Del Monte Corporation in a bold move to unite its fragmented global brand. We analyze the strategy, the risks, and the future.

A new Philips report quantifies AI's benefits in healthcare, from saving time to catching errors. But the path to adoption is fraught with challenges.

As a deadly Ebola strain spreads without a vaccine, Dr. Patrick Soon-Shiong's foundation injects $10M and shifts its strategy to direct African aid.

Baidu denies military ties after being added to a Pentagon list, but beyond the PR battle lies the reality of US-China tech decoupling. What's the real cost?